
|Articles|January 30, 2006
FDA panel wants to ban certain OTC asthma inhalers
Advertisement
An FDA advisory panel has voted 11-7 to recommend that the FDA ban certain nonprescription inhalers because they contain propellants that harm the ozone layer. Among the products that would be affected by a ban is Wyeth Consumer Healthcare's Primatene Mist.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Gaps Between Expectations and Effects on Long COVID Contribute to Trust in Vaccines
2
Cardiovascular Disease Rates Increase for Patients With Mental Disorders During COVID-19 Pandemic
3
How Pharmacies’ Ability to Provide Behavioral Health Services is Growing | NCPA 2025
4
Pharmacy Technology Should Focus on Patient Engagement, Peer Insight | NCPA 2025
5


























































































































































